Neuren Pharmaceuticals Shares Surge 8.4% on Announcement of AU$50Mn Share Buyback Program

2 min read | November 14, 2024 12:21 PM AEDT | By Team Kalkine Media

Google News:

Neuren Pharmaceuticals Shares Surge 8.4% on Announcement of AU$50Mn Share Buyback Program — Image source: shutterstock

Recent News

Santos (ASX:STO) After the Takeover Collapse: Bargain or Value Trap?

Why Pro Medicus (ASX:PME) Is Leading the Growth Stock Conversation

Is 360 (ASX:360) Amid ASX 200 Revealing Growth’s New Reality?

Why 360 (ASX:360) ASX 200 Is Facing a New Growth Test

Make Kalkine Media
My Trusted Source

Highlights

Neuren Pharmaceuticals’ shares jumped 8.4% to AU$17.94, marking the highest level since August and making it the top gainer on the ASX 200 index.

The company launched a share buyback program, aiming to repurchase up to 3 million shares with a total value of AU$50 million.

Despite today’s surge, Neuren’s stock remains down 33.8% year-to-date.

Shares of Neuren Pharmaceuticals (ASX:NEU) soared by 8.4% to reach AU$17.94 in Thursday trading, their highest level since August 5, following the announcement of an on-market share buyback program. This surge positioned Neuren as the leading percentage gainer on the S&P/ASX 200 index for the day, indicating strong investor enthusiasm in response to the company's repurchase initiative.

The Australian drug manufacturer revealed plans to buy back up to AU$50 million (approximately US$32.47 million) in shares, aiming to acquire as many as 3 million shares on the market. The buyback price is set at AU$16.54 per share, based on the stock’s closing price on Wednesday, which reflects the company’s confidence in its long-term value and commitment to enhancing shareholder returns.

Neuren Pharmaceuticals, known for its focus on developing treatments for neurological disorders, has faced a challenging year on the stock market, with its shares still down by 33.8% year-to-date despite Thursday’s gains. The buyback program could potentially signal a strategic move to bolster investor confidence and stabilize share prices after a year of market volatility.

Analysts note that share buybacks often indicate that a company considers its shares to be undervalued and can create upward pressure on stock prices by reducing the number of shares available in the market. For Neuren, this move may reflect a longer-term view of growth prospects as it continues its development efforts within the pharmaceutical sector.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.